fbpx

1 Crysallis PORE REFINING AHA Daily Active Serum

(1 customer review)

£42.00

A product that keeps your skin glowing! It removes gently your dead skin cells to leave your skin looking and feeling amazing and clean. If yo are oily, it helps soak up the excess and reduce it over time. It is also gentle and will not sensitise the skin.

Contains the natural clinically proven AHAs, glycolic acid to gently remove the build-up of dead skin cells. It increases cell turnover to reveal fresh, younger-looking skin and it is effective at controlling breakouts, reducing pigmentation and fine lines and wrinkles.

Description

Directions

Can be used morning and night for all skin types, but sensitive are recommended to use only at night. Avoid contact with the eyes, rinse well if product enters the eyes. For external use only.

 

Ingredients:

  • Sodium Gluconate: Helps keep formulas stable and assists skin in retaining water.
  • Calendula Officinalis Flower Extract: Non-fragrant antioxidant plant extract that has skin-soothing and redness-reducing properties.
  • Benzyl Alcohol: A preservative with antibacterial and anti-fungal properties.
  • PEG-40 Hydrogenated Castor Oil: Emollient, emulsifying agent, and solubility-enhancing ingredient that imparts a soft feel on skin and minimizes moisture loss.
  • Citrus Reticulata Fruit Extract: Possesses strong antioxidant activity, as well as anti-collagenase and anti-elastase activity.
  • Helianthus Annuus Seed Oil: Helps replenish, strengthen, and soothe skin and is particularly beneficial for dry, dehydrated, or environmentally compromised skin.
  • Saccharide Isomerate: A water-binding agent and emollient, particularly helpful for dry skin.

1 review for 1 Crysallis PORE REFINING AHA Daily Active Serum

  1. Marie

    This has done wonders for my skin ! I was going through a awful breakout I’m now using this everyday and have seen a incredible difference with my breakout almost completely gone makes me skin feel so soft and hydrated !!

Add a review

Your email address will not be published.